{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T20:42:32Z","timestamp":1792788152767,"version":"4.5.0"},"reference-count":15,"publisher":"Springer Science and Business Media LLC","issue":"1","funder":[{"name":"Allergan Pharmaceutical Ireland Inc."}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Health Qual Life Outcomes"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1186\/s12955-015-0368-4","type":"journal-article","created":{"date-parts":[[2015,10,30]],"date-time":"2015-10-30T09:51:38Z","timestamp":1446198698000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Validation of a Dutch version of the Actionable 8-item screening questionnaire for neurogenic bladder overactivity in multiple sclerosis: an observational web-based study"],"prefix":"10.1186","volume":"13","author":[{"given":"Peter Joseph","family":"Jongen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bertil F. M.","family":"Blok","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John P.","family":"Heesakkers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Heerings","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wim A.","family":"Lemmens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rogier","family":"Donders","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,10,30]]},"reference":[{"key":"368_CR1","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1016\/S0022-5347(01)61760-9","volume":"161","author":"SE Litwiller","year":"1999","unstructured":"Litwiller SE, Frohman EM, Zimmern PE. Multiple sclerosis and the urologist. J Urol. 1999;161:743\u201357.","journal-title":"J Urol"},{"key":"368_CR2","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1186\/1471-2377-14-74","volume":"14","author":"DH Tang","year":"2014","unstructured":"Tang DH, Colayco D, Piercy J, Patel V, Globe D, Chancellor MB. Impact of urinary incontinence on health-related quality of life, daily activities, and healthcare resource utilization in patients with neurogenic detrusor overactivity. BMC Neurol. 2014;14:74.","journal-title":"BMC Neurol"},{"key":"368_CR3","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1111\/bju.12505","volume":"113","author":"DH Tang","year":"2014","unstructured":"Tang DH, Colayco DC, Khalaf KM, Piercy J, Patel V, Globe D, et al. Impact of urinary incontinence on healthcare resource utilization, health-related quality of life and productivity in patients with overactive bladder. BJU Int. 2014;113:484\u201391.","journal-title":"BJU Int"},{"key":"368_CR4","doi-asserted-by":"crossref","first-page":"182","DOI":"10.7224\/1537-2073.2012-049","volume":"15","author":"J Burks","year":"2013","unstructured":"Burks J, Chancellor M, Bates D, Denys P, Macdiarmid S, Nitti V, et al. Development and validation of the actionable bladder symptom screening tool for multiple sclerosis patients. Int J MS Care. 2013;15:182\u201392.","journal-title":"Int J MS Care"},{"key":"368_CR5","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1016\/j.juro.2009.12.029","volume":"183","author":"ST Mahajan","year":"2010","unstructured":"Mahajan ST, Patel PB, Marrie RA. Under treatment of overactive bladder symptoms in patients with multiple sclerosis: an ancillary analysis of the NARCOMS patient registry. J Urol. 2010;183:1432\u20137.","journal-title":"J Urol"},{"key":"368_CR6","first-page":"S139","volume":"17 Suppl 5 Impr","author":"HL Zwibel","year":"2011","unstructured":"Zwibel HL, Smrtka J. Improving quality of life in multiple sclerosis: an unmet need. Am J Manag Care. 2011;17 Suppl 5 Improving:S139\u2013145.","journal-title":"Am J Manag Care"},{"key":"368_CR7","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1186\/1471-2377-13-78","volume":"13","author":"D Bates","year":"2013","unstructured":"Bates D, Burks J, Globe D, Signori M, Hudgens S, Denys P, et al. Development of a short form and scoring algorithm from the validated actionable bladder symptom screening tool. BMC Neurol. 2013;13:78.","journal-title":"BMC Neurol"},{"key":"368_CR8","unstructured":"Sport MoHWa. Wet medisch-wetenschappelijk onderzoek met mensen. Dutch Medical Research InvolvingHuman Subjects Act (WMO). International Publication Series Health, Welfare and Sport. The Hague, 1997;(2):1\u201334. http:\/\/wetten.overheid.nl\/BWBR0009408 . Accessed 20 Oct 2015."},{"key":"368_CR9","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1007\/BF02260859","volume":"4","author":"BG Vickrey","year":"1995","unstructured":"Vickrey BG, Hays RD, Harooni R, Myers LW, Ellison GW. A health-related quality of life measure for multiple sclerosis. Qual Life Res. 1995;4:187\u2013206.","journal-title":"Qual Life Res"},{"key":"368_CR10","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1191\/1352458503ms884oa","volume":"9","author":"J Lechner-Scott","year":"2003","unstructured":"Lechner-Scott J, Kappos L, Hofman M, Polman CH, Ronner H, Montalban X, et al. Can the expanded disability status scale be assessed by telephone? Mult Scler. 2003;9:154\u20139.","journal-title":"Mult Scler"},{"key":"368_CR11","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1212\/WNL.33.11.1444","volume":"33","author":"JF Kurtzke","year":"1983","unstructured":"Kurtzke JF. Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology. 1983;33:1444\u201352.","journal-title":"Neurology"},{"key":"368_CR12","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1080\/09638280701256868","volume":"30","author":"K Wynia","year":"2008","unstructured":"Wynia K, Middel B, van Dijk JP, de Ruiter H, de Keyser J, Reijneveld SA. The Multiple Sclerosis impact Profile (MSIP). Development and testing psychometric properties of an ICF-based health measure. Disabil Rehabil. 2008;30:261\u201374.","journal-title":"Disabil Rehabil"},{"key":"368_CR13","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1080\/09638280701476193","volume":"30","author":"K Wynia","year":"2008","unstructured":"Wynia K, Middel B, de Ruiter H, van Dijk JP, de Keyser JH, Reijneveld SA. Stability and relative validity of the Multiple Sclerosis Impact Profile (MSIP). Disabil Rehabil. 2008;30:1027\u201338.","journal-title":"Disabil Rehabil"},{"key":"368_CR14","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1016\/j.urology.2005.09.035","volume":"67","author":"C Acquadro","year":"2006","unstructured":"Acquadro C, Kopp Z, Coyne KS, Corcos J, Tubaro A, Choo MS, et al. Translating overactive bladder questionnaires in 14 languages. Urol. 2006;67:536\u201340.","journal-title":"Urol"},{"key":"368_CR15","doi-asserted-by":"crossref","first-page":"827","DOI":"10.2165\/00023210-200822100-00004","volume":"22","author":"RA Rudick","year":"2008","unstructured":"Rudick RA, Miller DM. Health-related quality of life in multiple sclerosis: current evidence, measurement and effects of disease severity and treatment. CNS Drugs. 2008;22:827\u201339.","journal-title":"CNS Drugs"}],"container-title":["Health and Quality of Life Outcomes"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12955-015-0368-4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,23]],"date-time":"2017-06-23T18:34:30Z","timestamp":1498242870000},"score":1,"resource":{"primary":{"URL":"http:\/\/hqlo.biomedcentral.com\/articles\/10.1186\/s12955-015-0368-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,10,30]]},"references-count":15,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["368"],"URL":"https:\/\/doi.org\/10.1186\/s12955-015-0368-4","relation":{},"ISSN":["1477-7525"],"issn-type":[{"value":"1477-7525","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,10,30]]},"article-number":"175"}}